408 related articles for article (PubMed ID: 24629023)
1. IL-37 inhibits the production of inflammatory cytokines in peripheral blood mononuclear cells of patients with systemic lupus erythematosus: its correlation with disease activity.
Ye L; Ji L; Wen Z; Zhou Y; Hu D; Li Y; Yu T; Chen B; Zhang J; Ding L; Du J; Huang Z
J Transl Med; 2014 Mar; 12():69. PubMed ID: 24629023
[TBL] [Abstract][Full Text] [Related]
2. Plasma interleukin-37 is increased and inhibits the production of inflammatory cytokines in peripheral blood mononuclear cells in systemic juvenile idiopathic arthritis patients.
Feng M; Kang M; He F; Xiao Z; Liu Z; Yao H; Wu J
J Transl Med; 2018 Oct; 16(1):277. PubMed ID: 30305171
[TBL] [Abstract][Full Text] [Related]
3. Increased expression of IL-37 in patients with Graves' disease and its contribution to suppression of proinflammatory cytokines production in peripheral blood mononuclear cells.
Li Y; Wang Z; Yu T; Chen B; Zhang J; Huang K; Huang Z
PLoS One; 2014; 9(9):e107183. PubMed ID: 25226272
[TBL] [Abstract][Full Text] [Related]
4. Elevation of human tumor necrosis factor-like weak inducer of apoptosis in peripheral blood mononuclear cells is correlated with disease activity and lupus nephritis in patients with systemic lupus erythematosus.
Liu ZC; Zhou QL; Li XZ; Yang JH; Ao X; Veeraragoo P; Zuo XX
Cytokine; 2011 Mar; 53(3):295-300. PubMed ID: 21163672
[TBL] [Abstract][Full Text] [Related]
5. Increased serum IL-36α and IL-36γ levels in patients with systemic lupus erythematosus: Association with disease activity and arthritis.
Mai SZ; Li CJ; Xie XY; Xiong H; Xu M; Zeng FQ; Guo Q; Han YF
Int Immunopharmacol; 2018 May; 58():103-108. PubMed ID: 29571080
[TBL] [Abstract][Full Text] [Related]
6. Interferon-lambda1 induces peripheral blood mononuclear cell-derived chemokines secretion in patients with systemic lupus erythematosus: its correlation with disease activity.
Wu Q; Yang Q; Lourenco E; Sun H; Zhang Y
Arthritis Res Ther; 2011 Jun; 13(3):R88. PubMed ID: 21679442
[TBL] [Abstract][Full Text] [Related]
7. BAFF-R and TACI expression on CD3+ T cells: Interplay among BAFF, APRIL and T helper cytokines profile in systemic lupus erythematosus.
Salazar-Camarena DC; Ortíz-Lazareno P; Marín-Rosales M; Cruz A; Muñoz-Valle F; Tapia-Llanos R; Orozco-Barocio G; Machado-Contreras R; Palafox-Sánchez CA
Cytokine; 2019 Feb; 114():115-127. PubMed ID: 30467093
[TBL] [Abstract][Full Text] [Related]
8. Interleukin-25 is upregulated in patients with systemic lupus erythematosus and ameliorates murine lupus by inhibiting inflammatory cytokine production.
Li Y; Wang R; Liu S; Liu J; Pan W; Li F; Li J; Meng D
Int Immunopharmacol; 2019 Sep; 74():105680. PubMed ID: 31200339
[TBL] [Abstract][Full Text] [Related]
9. miR-98 Modulates Cytokine Production from Human PBMCs in Systemic Lupus Erythematosus by Targeting IL-6 mRNA.
Yuan S; Tang C; Chen D; Li F; Huang M; Ye J; He Z; Li W; Chen Y; Lin X; Wang X; Cai X
J Immunol Res; 2019; 2019():9827574. PubMed ID: 31886314
[TBL] [Abstract][Full Text] [Related]
10. Gene expression of cytokines (TNF-α, IFN-γ), serum profiles of IL-17 and IL-23 in paediatric systemic lupus erythematosus.
Rana A; Minz RW; Aggarwal R; Anand S; Pasricha N; Singh S
Lupus; 2012 Sep; 21(10):1105-12. PubMed ID: 22759859
[TBL] [Abstract][Full Text] [Related]
11. Serum progranulin levels are elevated in patients with systemic lupus erythematosus, reflecting disease activity.
Tanaka A; Tsukamoto H; Mitoma H; Kiyohara C; Ueda N; Ayano M; Ohta S; Inoue Y; Arinobu Y; Niiro H; Horiuchi T; Akashi K
Arthritis Res Ther; 2012 Nov; 14(6):R244. PubMed ID: 23140401
[TBL] [Abstract][Full Text] [Related]
12. 4-Octyl Itaconate Activates Nrf2 Signaling to Inhibit Pro-Inflammatory Cytokine Production in Peripheral Blood Mononuclear Cells of Systemic Lupus Erythematosus Patients.
Tang C; Wang X; Xie Y; Cai X; Yu N; Hu Y; Zheng Z
Cell Physiol Biochem; 2018; 51(2):979-990. PubMed ID: 30466076
[TBL] [Abstract][Full Text] [Related]
13. Altered AKT1 and MAPK1 gene expression on peripheral blood mononuclear cells and correlation with T-helper-transcription factors in systemic lupus erythematosus patients.
Garcia-Rodriguez S; Callejas-Rubio JL; Ortego-Centeno N; Zumaquero E; Ríos-Fernandez R; Arias-Santiago S; Navarro P; Sancho J; Zubiaur M
Mediators Inflamm; 2012; 2012():495934. PubMed ID: 23125486
[TBL] [Abstract][Full Text] [Related]
14. IL-38: A novel cytokine in systemic lupus erythematosus pathogenesis.
Xu WD; Su LC; Liu XY; Wang JM; Yuan ZC; Qin Z; Zhou XP; Huang AF
J Cell Mol Med; 2020 Nov; 24(21):12379-12389. PubMed ID: 33079487
[TBL] [Abstract][Full Text] [Related]
15. Aberrant expression of regulatory cytokine IL-35 in patients with systemic lupus erythematosus.
Cai Z; Wong CK; Kam NW; Dong J; Jiao D; Chu M; Lam CW; Tam LS
Lupus; 2015 Oct; 24(12):1257-66. PubMed ID: 25966926
[TBL] [Abstract][Full Text] [Related]
16. Brief Report: Interleukin-38 Exerts Antiinflammatory Functions and Is Associated With Disease Activity in Systemic Lupus Erythematosus.
Rudloff I; Godsell J; Nold-Petry CA; Harris J; Hoi A; Morand EF; Nold MF
Arthritis Rheumatol; 2015 Dec; 67(12):3219-25. PubMed ID: 26314375
[TBL] [Abstract][Full Text] [Related]
17. Increased spontaneous but decreased mitogen-stimulated expression and excretion of interleukin 18 by mononuclear cells in patients with active systemic lupus erythematosus.
Lee HT; Chen WS; Sun KH; Chou CT; Tsai CY
J Rheumatol; 2009 Sep; 36(9):1910-6. PubMed ID: 19605669
[TBL] [Abstract][Full Text] [Related]
18. Interleukin-37 is increased in ankylosing spondylitis patients and associated with disease activity.
Chen B; Huang K; Ye L; Li Y; Zhang J; Zhang J; Fan X; Liu X; Li L; Sun J; Du J; Huang Z
J Transl Med; 2015 Jan; 13():36. PubMed ID: 25627863
[TBL] [Abstract][Full Text] [Related]
19. Expression of high mobility group box chromosomal protein 1 and its modulating effects on downstream cytokines in systemic lupus erythematosus.
Li J; Xie H; Wen T; Liu H; Zhu W; Chen X
J Rheumatol; 2010 Apr; 37(4):766-75. PubMed ID: 20110525
[TBL] [Abstract][Full Text] [Related]
20. Decreased expressions of the TNF-alpha signaling adapters in peripheral blood mononuclear cells (PBMCs) are correlated with disease activity in patients with systemic lupus erythematosus.
Zhu L; Yang X; Chen W; Li X; Ji Y; Mao H; Nie J; Yu X
Clin Rheumatol; 2007 Sep; 26(9):1481-9. PubMed ID: 17235653
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]